rdf:type |
|
lifeskim:mentions |
umls-concept:C0005695,
umls-concept:C0021083,
umls-concept:C0021756,
umls-concept:C0030705,
umls-concept:C0034819,
umls-concept:C0085957,
umls-concept:C0205124,
umls-concept:C0441889,
umls-concept:C0442124,
umls-concept:C1456820,
umls-concept:C1511790,
umls-concept:C1524119
|
pubmed:issue |
2
|
pubmed:dateCreated |
1994-3-25
|
pubmed:abstractText |
To investigate the presence of urinary cytokines, after bacillus Calmette-Guérin (BCG) therapy, in order to provide further insight into the mechanisms of action of intravesical BCG therapy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0090-4295
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
187-90
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:8116114-Administration, Intravesical,
pubmed-meshheading:8116114-BCG Vaccine,
pubmed-meshheading:8116114-Carcinoma, Transitional Cell,
pubmed-meshheading:8116114-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:8116114-Female,
pubmed-meshheading:8116114-Follow-Up Studies,
pubmed-meshheading:8116114-Humans,
pubmed-meshheading:8116114-Interleukin-2,
pubmed-meshheading:8116114-Male,
pubmed-meshheading:8116114-Middle Aged,
pubmed-meshheading:8116114-Receptors, Interleukin-2,
pubmed-meshheading:8116114-Time Factors,
pubmed-meshheading:8116114-Tumor Necrosis Factor-alpha,
pubmed-meshheading:8116114-Urinary Bladder Neoplasms
|
pubmed:year |
1994
|
pubmed:articleTitle |
Detection of urinary interleukin-2, interleukin-2 receptor, and tumor necrosis factor levels in patients with superficial bladder tumors after intravesical BCG immunotherapy.
|
pubmed:affiliation |
Department of Urology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
|
pubmed:publicationType |
Journal Article
|